Fred Eshelman Distinguished Professor Leaf Huang, Ph.D., is the recipient of the Journal of Drug Targeting Lifetime Achievement Award for 2018 for his many outstanding contributions to drug delivery and targeting. The Lifetime Achievement Award is an annual award given … Read more
In a rapid-fire series of breakthroughs in just under a year, researchers at the UNC Eshelman School of Pharmacy have made another stunning advance in the development of an effective glioblastoma treatment for a common and aggressive brain cancer. The … Read more
Sam Lai, Ph.D., has been promoted to associate professor with tenure in the Division of Molecular Pharmaceutics. Lai’s research focuses on mucosal immunology and mucosal barriers to infectious disease, antibody response to synthetic materials, targeted nanoparticle delivery using bispecific fusion … Read more
Researchers at the University of North Carolina at Chapel Hill seeking a better treatment for glioblastoma have discovered that removing a brain tumor causes any cancer left behind to grow 75 percent faster than the original tumor did, which helps … Read more
Lei Miao, a graduate student in the Division of Molecular Pharmaceutics, is the first recipient of the Feng Liu Graduate Student Award. Maio’s thesis topic is the “Role of Tumor Desmoplasia in Nanoparticle Delivery of Drugs and Genes.” She has … Read more
Mucommune, LLC, is the fourth company spun out of the research enterprise at the UNC Eshelman School of Pharmacy to take up residence in the Eshelman Institute for Innovation MicroIncubator located at the School. Mucommune was born in 2015 from … Read more
From March 14 to 18, scientists from industry and academia converged on the UNC Eshelman School of Pharmacy to learn about and to get hands-on experience with the latest advances in nanomedicine at the inaugural Carolina Nanoformulation Workshop. The workshop … Read more
Scientists at the UNC Eshelman School of Pharmacy are using the newest version of a Nobel Prize–winning technology for the first time to build cancer-killing stem cells that hunt down and mop up the remnants of invasive brain tumors, promising … Read more
Elizabeth Gurysh, Ph.D., was awarded the pharmaceutics postdoctoral fellowship by the PhRMA Foundation, whose mission is to support young scientists in disciplines important to the pharmaceutical industry to encourage them to pursue careers in research and education related to drug … Read more
Michael Jay, Ph.D., Fred Eshelman Distinguished Professor of Molecular Pharmaceutics, is the 2016 recipient of the Distinguished Teaching Award for Postbaccalaureate Instruction from the University of North Carolina at Chapel Hill. Jay will be recognized along with other recipients during … Read more
